222 related articles for article (PubMed ID: 15369440)
1. [Homogeneous functional group, value--added tax, eye drops and ocular injections, personal computer and secundum artem].
Recio Blázquez ML
Farm Hosp; 2004; 28(4):291-3. PubMed ID: 15369440
[No Abstract] [Full Text] [Related]
2. [Eye drops--quality and stability according to the pharmacopoeia].
Honegger H; Werry H
Med Monatsschr; 1977 Dec; 31(12):536-9. PubMed ID: 593216
[No Abstract] [Full Text] [Related]
3. Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases.
Partal A; Scott E
Transfus Med; 2011 Aug; 21(4):271-7. PubMed ID: 21371142
[TBL] [Abstract][Full Text] [Related]
4. Use of drugs in the eye.
Ellis PP
GP; 1968 Oct; 38(4):99-108. PubMed ID: 5679524
[No Abstract] [Full Text] [Related]
5. [The use of magnetic fields in ophthalmology].
Skrinnik AV; Moiseeva NN
Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478
[No Abstract] [Full Text] [Related]
6. [Kinetics of drugs in ophthalmology].
Lapalus P; Moulin G; Fredj D
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():31-48. PubMed ID: 2866043
[No Abstract] [Full Text] [Related]
7. Treatment of a common ocular complaint.
Straughan JL
S Afr Med J; 1979 Mar; 55(9):320. PubMed ID: 441892
[No Abstract] [Full Text] [Related]
8. [Ocular dressing with installation of eye drops].
André F
Soins; 1985 May; (453):III-IV. PubMed ID: 3854514
[No Abstract] [Full Text] [Related]
9. Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Jan; 133(1):9-10. PubMed ID: 25256889
[No Abstract] [Full Text] [Related]
10. [Microbiological analysis of drugs used in the eye department of the hospital].
Kadlecová O; Entnerová K
Cesk Oftalmol; 1968 Sep; 24(5):364-70. PubMed ID: 5680655
[No Abstract] [Full Text] [Related]
11. Considerations for randomizing 1 eye or 2 eyes.
Bunce C; Wormald R
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291489
[No Abstract] [Full Text] [Related]
12. Considerations for randomizing 1 eye or 2 eyes--reply.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291566
[No Abstract] [Full Text] [Related]
13. [Polyacrylamide prolongation solution for eye drops].
Maĭchuk IuF; Tishina IF
Vestn Oftalmol; 1971; 6():60-3. PubMed ID: 5144440
[No Abstract] [Full Text] [Related]
14. [Prescription moderated preparation of bacteria non-contaminated eyedrop solutions and eye ointment 1].
Frauch P
Pharm Acta Helv; 1970 Jan; 45(1):1-17. PubMed ID: 4908302
[No Abstract] [Full Text] [Related]
15. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
16. [A contribution to the stability of watery adrenaline bitartrate eye drops].
Fürtig W; Methke I
Pharm Prax; 1965; 11():248-51. PubMed ID: 5888294
[No Abstract] [Full Text] [Related]
17. Pharmacoeconomics of new medications for common chronic ophthalmic diseases.
Hirsch JD; Morello C; Singh R; Robbins SL
Surv Ophthalmol; 2007; 52(6):618-33. PubMed ID: 18029270
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
19. Corticosteroid eye drops and red eyes.
Morgan PE
Mo Med; 1978 Jan; 75(1):29-30. PubMed ID: 622077
[No Abstract] [Full Text] [Related]
20. [Introduction of drugs into Tenon's space].
Remizov MS; Balueva LI
Vestn Oftalmol; 1973; 1():36-8. PubMed ID: 4777165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
